Health Benefits of Dance Exercise
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age35-70
SponsorUniversity of Thessaly
About this trial
In Greece, people of different age groups, including young children to older adults, participate in dance exercise training. Although it is well-known that regular participation in dancing is associated with benefits such as entertainment, socialization and increased physical activity, the long-term effects of dancing on metabolic and mental health as well as physical performance remain largely unknown. Therefore, the aim of this study is to investigate the effects of a 6-month dancing exercise intervention on metabolic and mental health and physical performance in premenopausal and postmenopausal women.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Free of musculoskeletal injuries
Free of chronic non-communicable diseases
Normal menstrual cycle (for premenopausal women)
No recent childbirth (previous 12 months) (for premenopausal women)
Disqualifiers
Pregnancy (for premenopausal women)
Contraindications to exercise training
Illness or other medical condition
Use of medication
Trial design
Design model
Parallel
Treatments tested in this trial
Exercise training
Other interventionThis intervention will consist of two weekly dance exercise training sessions over a 6-month period. Each session will be performed under supervision and include a 10-min warm up (2-3 dances of very slow tempo), a 45-min main dance exercise session (\~15 dances of various tempos i.e. slow, moderate and fast tempo) and a 5-min cool-down period (walking and stretching)
No exercise training
Other interventionIt will include only habitual physical activity level without participating in any form of exercise training
Treatment groups
40 Participants
are divided into 2 treatment groupsGroup A: Control GroupActive comparator 1 intervention
Group B: Experimental GroupExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Change in glucose concentration
Fasting glucose concentration will be determined in blood
Time frame
At baseline and 6 months2
Change in insulin concentration
Fasting insulin concentration will be determined in blood
Time frame
At baseline and 6 months3
Change in total cholesterol concentration
Total cholesterol concentration will be determined in blood
Time frame
At baseline and 6 months4
Change in HDL cholesterol concentration
HDL cholesterol concentration will be determined in blood
Time frame
At baseline and 6 monthsSecondary outcomes
1
Change in dietary intake
Dietary intake will be monitored using diet recalls
Time frame
At baseline and 6 months2
Change in daily number of steps
Daily number of steps performed will be assessed using accelerometers
Time frame
At baseline and 6 months3
Change in daily time spent in moderate-to-vigorous physical activity
The time spent in moderate-to-vigorous physical activity will be assessed using accelerometers
Time frame
At baseline and 6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov